Vanda Pharmaceuticals (VNDA) Amortizatization of Intangibles (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Amortizatization of Intangibles of $136000.0 in Q1 2026, down 92.24% quarter-over-quarter from $1.8 million in Q4 2025, and down 81.84% year-over-year from $749000.0 in Q1 2025.
Vanda Pharmaceuticals' Amortizatization of Intangibles history runs 17 years deep, the most recent figure standing at $136000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 81.84% year-over-year to $136000.0; the TTM figure through Mar 2026 stood at $5.4 million (down 7.74% YoY), while the FY2025 annual figure was $7.0 million, changed 0.19% from the prior year.
- Amortizatization of Intangibles came in at $136000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $1.8 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.3 million in Q1 2023 to a low of $136000.0 in Q1 2026.
- A 5-year average of $1.2 million and a median of $1.5 million in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles soared 472.0% in 2023 and sank 81.84% in 2026, its largest moves.
- Vanda Pharmaceuticals' Amortizatization of Intangibles stood at $1.8 million in 2022, then tumbled by 45.78% to $990000.0 in 2023, then surged by 50.91% to $1.5 million in 2024, then advanced by 17.27% to $1.8 million in 2025, then slumped by 92.24% to $136000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $136000.0, $1.8 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 136,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 136,000.00 |
| Mar 31, 2026 | 136,000.00 |
| Dec 31, 2025 | 1.75 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 749,000.00 |
| Mar 31, 2025 | 749,000.00 |
| Dec 31, 2024 | 1.49 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 990,000.00 |
| Dec 31, 2023 | 990,000.00 |
| Sep 30, 2023 | 400,000.00 |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 400,000.00 |
| Mar 31, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 400,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 379,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 369,000.00 |
| Dec 31, 2021 | 369,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Mar 31, 2021 | -490,000.00 |
| Mar 31, 2021 | -490,000.00 |
| Dec 31, 2020 | 370,000.00 |
| Dec 31, 2020 | 370,000.00 |
| Sep 30, 2020 | 369,000.00 |
| Sep 30, 2020 | 369,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Mar 31, 2020 | 370,000.00 |
| Mar 31, 2020 | 370,000.00 |
| Dec 31, 2019 | 2.00 Mn |
| Dec 31, 2019 | 2.00 Mn |
| Sep 30, 2019 | 400,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 379,000.00 |
| Jun 30, 2019 | 379,000.00 |
| Mar 31, 2019 | 380,000.00 |
| Mar 31, 2019 | 380,000.00 |
| Dec 31, 2018 | 380,000.00 |
| Dec 31, 2018 | 380,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 398,000.00 |
| Jun 30, 2018 | 398,000.00 |
| Mar 31, 2018 | 208,000.00 |
| Mar 31, 2018 | 208,000.00 |
| Dec 31, 2017 | 432,000.00 |
| Dec 31, 2017 | 432,000.00 |
| Sep 30, 2017 | 432,000.00 |
| Sep 30, 2017 | 432,000.00 |
| Jun 30, 2017 | 432,000.00 |
| Jun 30, 2017 | 432,000.00 |
| Mar 31, 2017 | 454,000.00 |
| Mar 31, 2017 | 454,000.00 |
| Dec 31, 2016 | -8.89 Mn |
| Dec 31, 2016 | -8.89 Mn |
| Sep 30, 2016 | 2.94 Mn |
| Sep 30, 2016 | 2.94 Mn |
| Jun 30, 2016 | 2.94 Mn |
| Jun 30, 2016 | 2.94 Mn |
| Mar 31, 2016 | -28,000.00 |
| Mar 31, 2016 | -28,000.00 |
| Dec 31, 2015 | 2.94 Mn |
| Dec 31, 2015 | 2.94 Mn |
| Sep 30, 2015 | 2.94 Mn |
| Sep 30, 2015 | 2.94 Mn |
| Jun 30, 2015 | 2.94 Mn |
| Jun 30, 2015 | 2.94 Mn |
| Mar 31, 2015 | 4.14 Mn |
| Mar 31, 2015 | 4.14 Mn |
| Dec 31, 2014 | 2.39 Mn |
| Dec 31, 2014 | 2.39 Mn |
| Sep 30, 2014 | 536,000.00 |
| Sep 30, 2014 | 536,000.00 |
| Jun 30, 2014 | 617,000.00 |
| Jun 30, 2014 | 617,000.00 |
| Mar 31, 2014 | -53,000.00 |
| Mar 31, 2014 | -53,000.00 |
| Dec 31, 2013 | -1.27 Mn |
| Dec 31, 2013 | -1.27 Mn |
| Sep 30, 2013 | 377,000.00 |
| Sep 30, 2013 | 377,000.00 |
| Jun 30, 2013 | 372,000.00 |
| Jun 30, 2013 | 372,000.00 |
| Mar 31, 2013 | 369,000.00 |
| Mar 31, 2013 | 369,000.00 |
| Dec 31, 2012 | 1.91 Mn |
| Dec 31, 2012 | 1.91 Mn |
| Sep 30, 2012 | 377,000.00 |
| Sep 30, 2012 | 377,000.00 |
| Jun 30, 2012 | 372,000.00 |
| Jun 30, 2012 | 372,000.00 |
| Mar 31, 2012 | 369,000.00 |
| Mar 31, 2012 | 369,000.00 |
| Dec 31, 2011 | -126,000.00 |
| Dec 31, 2011 | -126,000.00 |
| Sep 30, 2011 | 377,000.00 |
| Sep 30, 2011 | 377,000.00 |
| Jun 30, 2011 | 372,000.00 |
| Jun 30, 2011 | 372,000.00 |
| Mar 31, 2011 | 369,000.00 |
| Mar 31, 2011 | 369,000.00 |
| Dec 31, 2010 | -1.33 Mn |
| Dec 31, 2010 | -1.33 Mn |
| Sep 30, 2010 | 377,000.00 |
| Sep 30, 2010 | 377,000.00 |
| Jun 30, 2010 | 372,000.00 |
| Jun 30, 2010 | 372,000.00 |